| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 6,300 | $40 | $239.4K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,520 | $30 | $85.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 470 | $110 | $51.3K |
| J0897 | Injection, denosumab, 1 mg | 2,400 | $20 | $45.6K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 1,900 | $20 | $30.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $120 | $24K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 300 | $80 | $22.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 18,750 | $1 | $18.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,140 | $1 | $16.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 80 | $140 | $12K |